BioNTech says vaccine 'neutralises' key mutation in UK, S.Africa strains
German company BioNTech said Friday a preliminary study shows that its vaccine works against the key mutation in coronavirus variants uncovered in Britain and South Africa which experts have said is more contagious than the original COVID-19 strain.
Tests carried out have shown that "antibodies from people who have received the Pfizer-BioNTech COVID-19 vaccine effectively neutralise SARS-CoV-2 with a key mutation that is also found in two highly transmissible strains," said the German company of the vaccine it developed with US group Pfizer.
© 2021 AFP
Citation:
BioNTech says vaccine 'neutralises' key mutation in UK, S.Africa strains (2021, January 8)
retrieved 10 May 2024
from https://medicalxpress.com/news/2021-01-biontech-vaccine-neutralises-key-mutation.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
